Measuring the Effects of Cannabis on Anxiety and Depression Among Cancer Patients
This study of cancer patients in Minnesota suggests that patterns of cannabis use that include relatively higher doses of CBD taken enterally may improve the quality of life of cancer survivors who report anxiety and depression. This study constructs a foundation for future research to improve the tailoring of cannabis-related educational materials to patients' needs and inform the training of healthcare professionals on how to recommend cannabis products for cancer survivors.
Authors
- Amy Trentham‐Dietz (ORCID: https://orcid.org/0000-0002-5971-4660)
- Faith Dickerson (ORCID: https://orcid.org/0000-0003-3800-2864)
- Betty Chewning (ORCID: https://orcid.org/0000-0003-1686-2329)
- Apoorva Reddy (ORCID: https://orcid.org/0000-0001-6966-7282)
- John M. Hampton (ORCID: https://orcid.org/0000-0003-0037-6211)
- Janvi Shah
- Susan Park (ORCID: https://orcid.org/0000-0002-5811-3943)
- Natalie Schmitz (ORCID: https://orcid.org/0000-0002-4229-919X)
Institutions
- Minnesota Department of Natural Resources (US)
- University of Wisconsin–Madison (US)
- University of Wisconsin Carbone Cancer Center (US)
- Wisconsin Division of Public Health (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1002/cam4.71342
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Georgia Clinical and Translational Science Alliance
- National Institutes of Health
- Institute for Clinical and Translational Research, University of Wisconsin, Madison
- National Center for Advancing Translational Sciences